Determination Of Glycemic Index And Glycemic Load Of Pronocte Protein Powder In Healthy Human Adult Subjects, Under Fasting Conditions

Azista Industries Pvt Ltd0 个研究点目标入组 13 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Normal healthy, adult subjects between 18-45 years of age, who voluntarily give their consent to participate in this trial.

•1. History or presence of significant:
•- Cardiovascular, pulmonary, hepatic, renal, hematological, gastrointestinal, endocrine, immunologic, dermatologic, neurologic or psychiatric disease.
•- Alcohol dependence, alcohol abuse or drug abuse within the past one year.
•- Moderate to heavy smoking ( >10 cigarettes/day) or consumption of tobacco products.
•- Asthma, urticaria or other allergic type reactions after taking any medication.
•2. Subjects who, through completion of the study, would have donated in excess of 500 ml of blood in 60 days or 450 ml in 10 week period or more than 900 ml of blood in 20 week period.
•3. Subjects who have participated in another clinical trial within 60 days of study start.
•4. Subjects who have (1) a Systolic blood pressure less than 90 mm of Hg and higher than 150 mm of Hg (2) Diastolic blood pressure less than 60 mm of Hg and more than 95 mm of Hg (3) Pulse rate below 50 / min. and above 105/min. Minor deviations (1-3 mm Hg) at check-in may be acceptable at the discretion of the physician / investigator.

发起方

Azista Industries Pvt Ltd